NegotiumBio
NegotiumBio provides external manufacturing strategy consulting for pharmaceutical and life science companies, focusing on diverse modalities including small and large molecules, cell & gene therapies (CAR-T, TCR, viral vector, plasmid, mAB, protein, CRISPR). They help clients mitigate outsourcing risks, optimize cost-effectiveness, and make informed decisions regarding contract manufacturing organizations (CMOs). Their services include market research, cost modeling, risk assessment, due diligence, negotiation support, and supplier relationship management. NegotiumBio also offers AI-driven business and technology development solutions through a strategic partnership. The company operates globally with offices in the USA and Switzerland.
NegotiumBio
NegotiumBio provides external manufacturing strategy consulting for pharmaceutical and life science companies, focusing on diverse modalities including small and large molecules, cell & gene therapies (CAR-T, TCR, viral vector, plasmid, mAB, protein, CRISPR). They help clients mitigate outsourcing risks, optimize cost-effectiveness, and make informed decisions regarding contract manufacturing organizations (CMOs). Their services include market research, cost modeling, risk assessment, due diligence, negotiation support, and supplier relationship management. NegotiumBio also offers AI-driven business and technology development solutions through a strategic partnership. The company operates globally with offices in the USA and Switzerland.